Pulmonary Embolism Clinical Trials
A listing of Pulmonary Embolism medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 199 clinical trials
A Randomized Trial of Ultrasound-facilitated, Catheter-directed, Thrombolysis Versus Anticoagulation for Acute Intermediate-high Risk Pulmonary Embolism: The Higher-risk Pulmonary Embolism Thrombolysis Study (HI-PEITHO)
There are many available treatments for pulmonary embolism (PE), but the best treatment for this condition is not known. The HI-PEITHO study will compare two treatment options that are both
- 0 views
- 10 Oct, 2022
- 41 locations
The PEERLESS Study (PEERLESS)
embolism (PE), and includes a non-randomized cohort of up to 150 subjects with an absolute contraindication to thrombolytics.
- 5 views
- 21 Oct, 2022
- 42 locations
sFlt1/PlGF and Selective Labor Induction to Prevent Preeclampsia at Term (PE37)
Preeclampsia (PE) affects ~5% of pregnancies. Although improved obstetrical care has significantly diminished associated maternal mortality, PE remains a leading cause of maternal
- 0 views
- 16 May, 2022
- 12 locations
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE (ASTER)
This is a Phase 3,multicenter, randomized, open-label, blinded endpoint evaluation study comparing the effect of abelacimab relative to apixaban on venous thromboembolism (VTE) recurrence and bleeding in patients with cancer associated VTE (ASTER)
- 0 views
- 04 Oct, 2022
- 12 locations
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE (MAGNOLIA)
This is a Phase 3, multicenter, open-label, blinded endpoint study to evaluate the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) recurrence and bleeding in patients with gastrointestinal (GI)/genitourinary (GU) cancer associated VTE (Magnolia)
- 0 views
- 04 Oct, 2022
- 1 location
Labor Induction in Preeclampsia High-risk Women (FORECAST-IOL)
Preeclampsia (PE) is one of the leading causes of maternal and perinatal morbidity and mortality. This pregnancy-specific disorder poses to both pregnant women and their offspring an increased
- 0 views
- 13 Jun, 2022
- 1 location
Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) (Jason)
/ Pulmonary Embolism (DVT/PE) recurrence.
- 0 views
- 04 Oct, 2022
- 1 location
Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis
superficial venous thrombosis (SVT), deep venous thrombosis (DVT), pulmonary embolism (PE)) in patients who have completed the cycle of therapy of the acute phase after superficial vein thrombosis.
- 9 views
- 02 Mar, 2022
- 1 location
LimPrOn: Limburg Pre-eclampsia Investigation (LimPrOn)
Background Multiple adaptations at the cardiovascular system occurs during pregnancy. In the pregnancy condition pre-eclampsia (PE), this adaptations are abnormal
- 43 views
- 03 Mar, 2022
- 8 locations
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism (HI-PRO)
VTE, defined as the composite of deep vein thrombosis and/or pulmonary embolism at 12 months. Secondary Efficacy Outcome: The composite of death due to cardiovascular cause, nonfatal
- 0 views
- 04 Oct, 2022
- 1 location